1. 73-96 of 277 « 1 2 3 4 5 6 7 ... 10 11 12 »
    1. Ruby Tuesday Board of Directors Rejects Highly-Conditional and Not Fully-Financed Acquisition

      Ruby Tuesday Board of Directors Rejects Highly-Conditional and Not Fully-Financed Acquisition

      The Board of Directors thoroughly evaluated Boaz's most recent proposal, including seeking clarifications from Boaz on the proposal, and unanimously determined that the proposal did not constitute and would not reasonably be expected to lead to a superior proposal as compared to the acquisition by ...

      Read Full Article
    2. Sarepta Therapeutics Elects Biopharmaceutical Veteran, Michael W. Bonney, to its Board of Directors

      Sarepta Therapeutics Elects Biopharmaceutical Veteran, Michael W. Bonney, to its Board of Directors

      "Sarepta and its board of directors are greatly enhanced with the appointment to our board of Mike Bonney, one of the most respected biopharmaceutical leaders," said M. Kathleen Behrens, Ph.D., chair of Sarepta's board of directors . "Mike's list of accomplishments is long and his impact on this industry ...

      Read Full Article
    3. RBR seeks Saudi Royal Family Investment for Credit Suisse

      RBR seeks Saudi Royal Family Investment for Credit Suisse

      (Reuters) - Activist investor RBR Capital Advisors has offered to connect Credit Suisse with the Saudi royal family as potential major shareholders for the Swiss bank, a person familiar with the matter told Reuters. The Swiss hedge fund led by Rudolf Bohli, which has a stake in Credit Suisse, last month pushed for a break up of the bank into three parts, hoping to double its market value...

      Read Full Article
    73-96 of 277 « 1 2 3 4 5 6 7 ... 10 11 12 »
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content